Inventor · disambiguated record
Reza Oliyai
Also filed as: OLIYAI REZA
23 granted patents·20 pending applications·1,031 citations·filing 1997–2021
97Inventor score
Files withGILEAD SCIENCES INC18GILEAD PHARMASSET LLC15DAHL TERRENCE C5BRISTOL-MYERS SQUIBB & GILEAD SCIENCES LLC3BONDY STEVEN S1
Top patents by PatentIndex Score
43 records- 0199US5977089AAntiviral phosphonomethoxy nucleotide analogs having increased oral bioavailabilityGILEAD SCIENCES INC·Filed 1998·Granted Nov 2, 1999·252 cites·3 claims
- 0298US6043230AAntiviral phosphonomethoxy nucleotide analogs having increased oral bioavailabilityGILEAD SCIENCES INC·Filed 1999·Granted Mar 28, 2000·191 cites·1 claims
- 0398US5922695AAntiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilabilityGILEAD SCIENCES INC·Filed 1997·Granted Jul 13, 1999·181 cites·31 claims
- 0497US8716264B2Compositions and methods for combination antiviral therapyDAHL TERRENCE C·Filed 2008·Granted May 6, 2014·46 cites·38 claims
- 0597US8592397B2Compositions and methods for combination antiviral therapyDAHL TERRENCE C·Filed 2008·Granted Nov 26, 2013·42 cites·26 claims
- 0695US9549941B2Compositions and methods for treating hepatitis C virusGILEAD PHARMASSET LLC·Filed 2014·Granted Jan 24, 2017·39 cites·23 claims
- 0795US8889159B2Compositions and methods for treating hepatitis C virusGILEAD PHARMASSET LLC·Filed 2012·Granted Nov 18, 2014·114 cites·37 claims
- 0895US6069249AAntiviral phosphonomethoxy nucleotide analogs having increased oral bioavailabilityGILEAD SCIENCES INC·Filed 1999·Granted May 30, 2000·67 cites·1 claims
- 0994US7754720B2Pyridazine compound and use thereofGILEAD SCIENCES INC·Filed 2007·Granted Jul 13, 2010·22 cites·16 claims
- 1093US9457036B2Compositions and methods for combination antiviral therapyGILEAD SCIENCES INC·Filed 2014·Granted Oct 4, 2016·6 cites·16 claims
- 1191US10086011B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2017·Granted Oct 2, 2018·8 cites·19 claims
- 1291US9757406B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted Sep 12, 2017·9 cites·16 claims
- 1391USRE38333EAntiviral phosphonomethoxy nucleotide analogs having increased oral bioavailabilityGILEAD SCIENCES INC·Filed 2002·Granted Nov 25, 2003·18 cites·5 claims
- 1490US11707479B2Combination formulation of two antiviral compoundsGILEAD SCIENCES INC·Filed 2021·Granted Jul 25, 2023·1 cites·34 claims
- 1590US11116783B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2020·Granted Sep 14, 2021·2 cites·58 claims
- 1689US8598185B2Unitary pharmaceutical dosage formDAHL TERRENCE C·Filed 2006·Granted Dec 3, 2013·12 cites·14 claims
- 1787US9018192B2Unitary pharmaceutical dosage formBRISTOL MYERS SQUIBB & GILEAD SCIENCES LLC·Filed 2013·Granted Apr 28, 2015·10 cites·2 claims
- 1886US9545414B2Unitary pharmaceutical dosage formBRISTOL-MYERS SQUIBB & GILEAD SCIENCES LLC·Filed 2015·Granted Jan 17, 2017·6 cites·19 claims
- 1982US8871271B2Method and composition for pharmaceutical productGILEAD SCIENCES INC·Filed 2013·Granted Oct 28, 2014·4 cites·9 claims
- 2077US9744181B2Compositions and methods for combination antiviral therapyGILEAD SCIENCES INC·Filed 2014·Granted Aug 29, 2017·0 cites·30 claims
- 2175US10039779B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted Aug 7, 2018·1 cites·16 claims
- 2274US2020188419A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2019·Application pending·0 cites
- 2371US2017273994A1Compositions and Methods for Combination Antiviral TherapyGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 2466US2006246130A1Compositions and methods for combination antiviral therapyDAHL TERRENCE C·Filed 2004·Application pending·0 cites
- 2566US2017232019A1Compositions and Methods for Combination Antiviral TherapyGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 2666US2006234982A1Compositions and methods for combination antiviral therapyDAHL TERRENCE C·Filed 2004·Application pending·0 cites
- 2764US2019240246A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2018·Application pending·0 cites
- 2862US8569487B2Pyridazine compound and use thereofBONDY STEVEN S·Filed 2007·Granted Oct 29, 2013·0 cites·1 claims
- 2962US2015064253A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 3061US2004224917A1Compositions and methods for combination antiviral therapyGILEAD SCIENCES INC·Filed 2004·Application pending·0 cites
- 3161US2019111068A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2018·Application pending·0 cites
- 3260US2014212491A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 3358US2017348342A1Compositions and methods for treating hepatitis c virusGILEAD PHARMASSET LLC·Filed 2017·Application pending·0 cites
- 3457US2014370102A1Method and composition for pharmaceutical productGILEAD SCIENCES INC·Filed 2014·Application pending·0 cites
- 3555US2004224916A1Compositions and methods for combination antiviral therapyGILEAD SCIENCES INC·Filed 2004·Application pending·0 cites
- 3655US2007077295A1Method and composition for pharmaceutical productGILEAD SCIENCES INC·Filed 2006·Application pending·0 cites
- 3753US2017079999A1Unitary pharmaceutical dosage formBRISTOL-MYERS SQUIBB & GILEAD SCIENCES LLC·Filed 2016·Application pending·0 cites
- 3853US2014212487A1Solid dispersion formulation of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 3953US2016120892A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2015·Application pending·0 cites
- 4052US2015064252A1Solid dispersion formulation of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 4142US10857102B2Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarateOLIYAI REZA·Filed 2011·Granted Dec 8, 2020·0 cites·5 claims
- 4240US2010285122A1Tablets for combination therapyGILEAD SCIENCES INC·Filed 2010·Application pending·0 cites
- 4338US2015150810A1Tablets for combination therapyGILEAD SCIENCES INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →